Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-16T15:58:46.309Z Has data issue: false hasContentIssue false
  • English
  • Français

Laryngeal dysplasia: a 10-year review of rates of progression to invasive carcinoma and treatment-specific outcomes in a regional ENT department in Northern Ireland

Published online by Cambridge University Press:  18 February 2022

G Donaldson Open the ORCID record for G Donaldson [Opens in a new window] ,
L McCadden ,
S Napier  and
T J Tan
G Donaldson*
Affiliation:
Department of Otolaryngology and Head & Neck Surgery, Royal Victoria Hospital, Belfast, Northern Ireland
L McCadden
Affiliation:
Department of Otolaryngology and Head & Neck Surgery, Royal Victoria Hospital, Belfast, Northern Ireland
S Napier
Affiliation:
Department of Pathology, Royal Victoria Hospital, Belfast, Northern Ireland
T J Tan
Affiliation:
Institute of Cardiovascular Science, University College London, UK
*
Author for correspondence: Dr Gavin Donaldson, Department of Otolaryngology and Head & Neck Surgery, Royal Victoria Hospital, Grosvenor Road, BelfastBT12 6BA, Northern Ireland, UK E-mail: gdonaldson06@qub.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Laryngeal dysplasia represents a complex pre-malignant condition characterised by a spectrum of mucosal changes, with a reported malignant transformation rate from dysplasia to invasive carcinoma of 14.0 per cent.

Objective

To identify whether increasing glottic dysplasia severity is associated with higher local malignant transformation rates or adverse clinical outcomes.

Methods

This retrospective cohort study identified 125 patients with any histopathological grade of glottic dysplasia over a 10-year period who were followed up for a standardised 10-year period.

Results

The malignant transformation rate was 21.8 per cent over 10 years, demonstrating a statistically significant greater risk with increasing dysplasia severity. The mean time to transformation was 52 months, with time to transformation statistically associated with increasing dysplasia severity. Rapid progression to carcinoma within 12 months occurred in 40 per cent of cases, and 58 per cent of subsequently diagnosed laryngeal squamous cell carcinomas were tumour stage T1.

Conclusion

Laryngeal dysplasia carries a significant malignant potential, appearing greatest within 12 months of diagnosis and with increasing severity of dysplasia.

Keywords

LarynxVocal CordsLaryngeal NeoplasmsPrecancerous ConditionsEpithelium
Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 136 , Issue 6 , June 2022 , pp. 547 - 553
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr G Donaldson takes responsibility for the integrity of the content of the paper

Presented orally at the Academic Meeting of the Irish Otolaryngology / Head and Neck Society, 10 October 2020, Dublin, Ireland (virtual meeting).

References

Weller, MD, Nankivell, PC, McConkey, C, Paleri, V, Mehanna, HM. The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis. Clin Otolaryngol 2010;35:364–72CrossRefGoogle ScholarPubMed
Spielmann, PM, Palmer, T, McClymont, L. 15-Year review of laryngeal and oral dysplasias and progression to invasive carcinoma. Eur Arch Otorhinolaryngol 2010;267:423–7CrossRefGoogle ScholarPubMed
Montgomery, J, White, A. A decade of laryngeal dysplasia in Paisley, Scotland. Eur Arch Otorhinolaryngol 2012;269:947–51CrossRefGoogle ScholarPubMed
Levendoski, EE, Leydon, C, Thibeault, SL. Vocal fold epithelial barrier in health and injury: a research review. J Speech Lang Hear Res 2014;57:1679–91CrossRefGoogle ScholarPubMed
Leemans, CR, Braakhuis, BJM, Brakenhoff, RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9–22CrossRefGoogle ScholarPubMed
Talamini, R, Bosetti, C, La Vecchia, C, Maso L, Dal, Levi, F, Bidoli, E et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 2002;13:957–64CrossRefGoogle ScholarPubMed
Halec, G, Holzinger, D, Schmitt, M, Flechtenmacher, C, Dyckhoff, G, Lloveras, B et al. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer 2013;109:172–83CrossRefGoogle Scholar
Westra, WH. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist. Semin Diagn Pathol 2015;32:42–53CrossRefGoogle ScholarPubMed
Pagliuca, G, Martellucci, S, Degener, AM, Pierangeli, A, Greco, A, Fusconi, M et al. Role of human papillomavirus in the pathogenesis of laryngeal dysplasia. Otolaryngol Head Neck Surg 2014;150:1018–23CrossRefGoogle ScholarPubMed
Lewis, JS, Ukpo, OC, Ma, XJ, Flanagan, JJ, Luo, Y, Thorstad, WL et al. Transcriptionally-active high-risk human papillomavirus is rare in oral cavity and laryngeal/hypopharyngeal squamous cell carcinomas - a tissue microarray study utilizing E6/E7 mRNA in situ hybridization. Histopathology 2012;60:982–91CrossRefGoogle ScholarPubMed
Li, X, Gao, L, Li, H, Gao, J, Yang, Y, Zhou, F et al. Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis 2013;207:479–88CrossRefGoogle ScholarPubMed
El-Naggar, AK, Chan, JKC, Grandis, JR, Takata, T, Slootweg, PJ, eds. World Health Organization Classification of Tumours: WHO Classification of Head and Neck Tumours, 4th edn, vol 9. Lyon: IARC Press, 2017Google Scholar
Barnes, L, Eveson, JW, Reichart, P, Sidransky, D, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon, 2005Google Scholar
Cho, KJ, Song, JS. Recent changes of classification for squamous intraepithelial lesions of the head and neck. Arch Pathol Lab Med 2018;142:829–32CrossRefGoogle ScholarPubMed
Sannino, NJB, Mehlum, CS, Grøntved, ÅM, Kjaergaard, T, Kiss, K, Godballe, C et al. Incidence and malignant transformation of glottic precursor lesions in Denmark. Acta Oncol 2020;59:596–602CrossRefGoogle ScholarPubMed
Mozet, C, Dietz, A. Laryngeal neoplasms [in German]. Laryngorhinootologie 2010;89:295–315CrossRefGoogle Scholar
Mehanna, H, Paleri, V, Robson, A, Wight, R, Helliwell, T. Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia. Clin Otolaryngol 2010;35:170–6CrossRefGoogle ScholarPubMed
Karatayli-Ozgursoy, S, Pacheco-Lopez, P, Hillel, AT, Best, SR, Bishop, JA, Akst, LM. Laryngeal dysplasia, demographics, and treatment: a single-institution, 20-year review. JAMA Otolaryngol Head Neck Surg 2015;141:313–18CrossRefGoogle ScholarPubMed
Donnelly, DW, Gavin, AT. Cancer Incidence Trends 1993-2013 with Projections to 2035. Belfast: NI Cancer Registry, 2016Google Scholar
National Joint Registry. National Joint Registry for England, Wales, Northern Ireland and the Isle of Man: 15th Annual Report 2018. Hemel Hempstead: National Joint Registry, 2018Google Scholar
Jeannon, JP, Soames, JV, Aston, V, Stafford, FW, Wilson, JA. Molecular markers in dysplasia of the larynx: expression of cyclin-dependent kinase inhibitors p21, p27 and p53 tumour suppressor gene in predicting cancer risk. Clin Otolaryngol Allied Sci 2004;29:698–704CrossRefGoogle ScholarPubMed
Isenberg, JS, Crozier, DL, Dailey, SH. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol 2008;117:74–9CrossRefGoogle ScholarPubMed
Luers, J, Sircar, K, Drebber, U, Beutner, D. The impact of laryngeal dysplasia on the development of laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014;271:539–45CrossRefGoogle ScholarPubMed
Gale, N, Poljak, M, Zidar, N. Update from the 4th edition of the World Health Organization Classification of Head and Neck Tumours: what is new in the 2017 WHO blue book for tumours of the hypopharynx, larynx, trachea and parapharyngeal space. Head Neck Pathol 2017;11:23–32CrossRefGoogle ScholarPubMed